Table 3.
Patient ID | AR type | C4d | % SV40-T antigen + tubules | DS | I | T | CI | CT | V | HMX | G | MM | CV | AH | Plasma cells1 |
1 | 2A | - | 8.4 | B3 | 3 | 3 | 1 | 3 | 1 | 1 | 0 | 1 | 2 | 2 | Yes |
2 | 2A | + | 0.7 | B2 | 3 | 1 | 3 | 3 | 1 | 3 | 0 | 0 | 1 | 0 | No |
3 | 2A | + | 8 | B2 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | Yes |
4 | 2A | + | 0.9 | B3 | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 2 | 1 | Yes |
5 | 2A | - | 11.5 | B3 | 1 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | No |
6 | 2A | - | 1.2 | B2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | No |
7 | 2A | - | 11.3 | B3 | 3 | 2 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 1 | No |
Plasma cells comprise > 20% of infiltrate. AR: Acute rejection; DS: Drachenberg stage; HMX: Interstitial hemorrhage; I: Interstitial inflammation; T: Tubulitis; CI: Interstitial fibrosis; CT: Tubular atrophy; V: Arteritis; G: Glomerulitis; MM: Mesangial matrix; CV: Vascular fibrous intimal thickening; AH: Arteriolar hyaline thickening.